Table 1.

Clinical Characteristics of Patients with Influenza A.

		Baloxavir	NAIs		p
No. of patients		111	184
			Oseltamivir	74
			Zanamivir	29
			Peramivir	4
			Laninamivir	77
Gender F/M/unknown		50/60/1	73/108/3		0.60
Age	Average (Range)	26.32±20.40 (2-72)	21.21±22.99 (0-91)		0.002
	0-4	4	32
	5-9	34	64
	10-19	18	30
	20-	55	58
Vaccinated this season yes/no/unknown		44/65/2	77/96/11		0.08
Duration from onset to drug administration		0.99±0.84	0.96±0.75		0.95
First symptoms (Multiple answers allowed)	Number of Total answer	242	157
	Fever	103 (39.9%)	60 (36.1%)		0.43
	Cough	51 (19.7%)	22 (13.3%)		0.08
	Sore throat	33 (12.8%)	26 (15.7%)		0.40
	Chills	7 (2.7%)	12 (7.2%)		0.03
	General malaise	12 (4.7%)	9 (5.4%)		0.72
	Head ache	15 (5.8%)	9 (5.4%)		0.86
	Myalgia or joint pain	7 (2.7%)	11 (6.6%)		0.05
	Nasal discharge	14 (5.4%)	8 (4.8%)		0.78

NAIs: neuraminidase inhibitors